Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing high-purity bendamustine hydrochloride

A high-purity technology of bendamustine hydrochloride, which is applied in the field of preparation of high-purity bendamustine hydrochloride, can solve problems such as failure to meet technical requirements, decrease in purity, and increase in content of similar substances, so as to improve product purity , Simplify operation and improve stability

Inactive Publication Date: 2011-01-19
JIANGSU AOSAIKANG PHARMA CO LTD
View PDF3 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] The chemical name of the intermediate 7 in the above reaction process is: ethyl 4-{5-[bis-(2-hydroxyethyl)amino]-1-methyl-2benzimidazole} butyrate, and the intermediate 7 reported in the literature is all It exists in the form of oil or jelly, which not only has low purity and poor stability, but cannot meet the necessary storage stability. During the storage process, it will inevitably lead to a decrease in purity, an increase in the content of similar substances, and a deepening of the color; Benzene hydrochloride obtained by chlorination and hydrolysis of ethyl 4-{5-[bis-(2-hydroxyethyl)amino]-1-methyl-2benzimidazole}butyrate in colloidal form The yield of damustine is extremely low, and the purity of the finished product can barely reach 99% after multiple recrystallization methods, but it is very difficult to continue to improve its purity on this basis, especially to control a single impurity below 0.1% It is impossible to achieve, it is difficult to meet the quality requirements of injection raw materials, and it also fails to reach the relevant technical requirements of the European Union's quality research technical guidelines ICH, which makes the research and development of bendamustine hydrochloride injection stagnant, making bendamustine hydrochloride Tin raw materials cannot be exported to European and American countries

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing high-purity bendamustine hydrochloride
  • Method for preparing high-purity bendamustine hydrochloride
  • Method for preparing high-purity bendamustine hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] The preparation of the 4-[5-[bis-(2-hydroxyethyl) amino]-1-methyl-2-benzimidazole] ethyl butyrate (intermediate) of embodiment 1 oily or colloidal

[0037] Oily or gum-like ethyl 4-[5-[bis-(2-hydroxyethyl)amino]-1-methyl-2-benzimidazole]butanoate (intermediate) can refer to the literature Journal fur praktische Chemie. 4. Prepared by Reihe.Band20.1963 (178-186), it can also be prepared by referring to the following method:

[0038] (1) Preparation of N-methyl-(2,4-dinitro)aniline (intermediate 1)

[0039] Add 438g of 2,4-dinitrochlorobenzene, 141g of methylamine hydrochloride, 573g of sodium acetate trihydrate and 1050ml of N,N-dimethylformamide into a 3L three-necked flask, heat to reflux, stir for 3h, TLC The reaction was stopped after detection of no raw material. After the reaction solution was slightly cooled, it was quickly poured into 3000ml of ice water, and allowed to stand for crystallization. After filtering, the filter cake was washed with an appropriate ...

Embodiment 2

[0061] Example 2 Preparation of 4-[5-[bis-(2-hydroxyethyl)amino]-1-methyl-2-benzimidazole] ethyl butyrate (intermediate) in solid form

[0062] Add ethyl acetate 100ml to the oily 4-[5-[bis-(2-hydroxyethyl)amino]-1-methyl-2-benzimidazole] ethyl butyrate 23g prepared in Example 1, and add ethyl acetate 100ml at room temperature (24°C) was stirred and dissolved to obtain a clear solution, 1000ml of n-heptane was added dropwise to the solution to precipitate a solid, the mixture was stirred and crystallized at room temperature 7 (24°C) for about 30 minutes, the solid was separated by filtration, and air-dried at 40°C to obtain Off-white solid: 14.7g, yield: 64.1%;

[0063] mp: 105-106.5°C, HPLC purity 98.8%.

[0064] Elemental analysis (C 18 h 27 N 3 o 4 ): Theory: C 61.87%; H 7.79%; N 12.02%;

[0065] Measured: C 61.82%; H 7.82%; N 12.01%;

[0066]1 H-NMR (CD 3 OD):

[0067] δ6.59, 7.03, 7.54(m, Ar-H), δ4.12(m, 2H), δ3.76(m, 2H), δ3.62(s, 3H), δ3.54(m, 2H) , δ2.55(m, 2...

Embodiment 3

[0073] The preparation of embodiment 3 bendamustine hydrochloride

[0074] The solid intermediate 4-[5-[bis-(2-hydroxyethyl)amino]-1-methyl-2-benzimidazole] ethyl butyrate (17.5g, 0.05mol) prepared in Example 2 1. Add 350ml of dichloromethane into a 1L reaction flask, stir mechanically, cool to 0-5°C, add 30ml of thionyl chloride dropwise, keep it warm at 0-5°C for 1h, and then react at room temperature for 3h. Concentrate under reduced pressure to dryness, add 350ml of concentrated hydrochloric acid to the viscous liquid, heat to reflux for 3h, add 3g of activated carbon, stir for 10min, filter while hot, concentrate the filtrate to dryness, add the residue to 50ml of purified water, stir to precipitate a solid . After filtration, the solid was vacuum-dried at 50° C. for 5 hours to obtain 15.9 g of crude bendamustine hydrochloride, with a yield of 80.6%, a purity of 98.3%, and a maximum purity of 0.55%.

[0075] Put 15.9 g of the above bendamustine hydrochloride crude produ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for preparing high-purity bendamustine hydrochloride. The method comprises the following steps of: (1) completely dissolving oily or colloidal 4-{5-[bis-(2-ethoxyl)amino]-1-methyl-2 benzimidazole}ethyl butyrate in 0.1 to 0.5g / ml solution of C1 to C4 alkyl acetate, wherein the dissolution temperature is 0 to 40 DEG C; (2) adding C5 to C8 hydrocarbons into the solution obtained in the step (1) dropwise, stirring the mixed solution at the temperature of between 10 DEG C below zero and 40 DEG C for crystallization, filtering the mixed solution to obtain solids of 4-{5-[bis-(2-ethoxyl)amino]-1-methyl-2 benzimidazole}ethyl butyrate; (3) performing chlorination on the solids of 4-{5-[bis-(2-ethoxyl)amino]-1-methyl-2 benzimidazole}ethyl butyrate obtained in the step 2 and thionyl chloride, performing hydrolysis by using concentrated hydrochloric acid to obtain salts, and purifying the salts to obtain the crude products of bendamustine hydrochloride; and (4) refining the crude products of bendamustine hydrochloride obtained in the step 3 by using water to obtain the finished products of bendamustine hydrochloride. The purity of the products prepared by the method of the invention is over 99.5 percent, and the content of single impurity is below 0.1 percent; and the method has the advantages of high yield, high product stability and suitability for industrialized production.

Description

technical field [0001] The invention relates to a preparation method of high-purity bendamustine hydrochloride, which belongs to the technical field of pharmaceutical production. Background technique [0002] Bendamustine hydrochloride, the chemical name is [1-methyl-2-(4'-butanoyl)-5-N,N'-di-(2'-chloroethyl)]-1H-benzo Imidazole hydrochloride, the structural formula is: [0003] [0004] Bendamustine hydrochloride was first developed in the early 1960s by Ozegowski and colleagues at the Institute for Microbiological Experiments in Jena, Germany. The purpose of the synthesis is to link an alkylated nitrogen mustard (a non-functional alkylating agent) to a purine and an amino acid. The major advantage of the newly synthesized compound over chlorambucil is its water solubility. Anger et al. published initial clinical results of the successful use of bendamustine in patients with plasmacytoma. Bendamustine was produced under the trade name Cytostasan by the pharmaceutical...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D235/16
Inventor 杜有国宗在伟陈磊杨建楠
Owner JIANGSU AOSAIKANG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com